Mylan opposes reconsideration in US antitrust case against Sanofi over insulin
MLex Summary: Mylan told a US federal judge that Sanofi-Aventis’ request for reconsideration in an antitrust case over an injectable form of a diabetes drug is a thinly veiled rehash of...To view the full article, register now.
Already a subscriber? Click here to view full article